Quality Assurance Engineer
Republic Services- Full Time
- Junior (1 to 2 years)
Candidates should have at least 1-2 years minimum working as a QA analyst with domain experience in the ServiceNow platform, demonstrated experience writing test plans, test cases and test strategies, experience performing both manual and automated testing with preference given to using tools such as ServiceNow ATF framework, ability to represent test plans and test coverage using enterprise tools such as Visio, Lucid Chart, Teams, Confluence, Jira and others, experience working in an Agile development environment with Product Owners and Developers, and experience working in a regulated environment within a global company (preferred). Working knowledge of ITIL processes or certification (preferred) is also desired.
The QA Analyst will partner with business analysts, developers, and stakeholders to understand new features, functionalities, and requirements to build comprehensive test plans, develop and document test cases, test strategies, identify test areas for automation and other test artifacts, collaborate with business analysts and stakeholders to create User Acceptance Test (UAT) scripts and facilitate their execution, build and maintain automated test scripts using tools such as ServiceNow Automated Test Framework (ATF), analyze test results, identify defects and work with developers to ensure timely resolution, stay up to date on latest ServiceNow features especially around testing, provide testing estimate and time estimates as part of Sprint Planning, and create test process and procedure documentation.
Supports genomics startups through funding and resources
Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.